BIOTIA
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid and precise infectious disease discovery. Their software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes.
BIOTIA
Industry:
Artificial Intelligence Bioinformatics Biotechnology Genetics Health Care Machine Learning Software
Founded:
2016-01-15
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.biotia.io
Total Employee:
11+
Status:
Active
Contact:
+1 888 685 2885
Email Addresses:
[email protected]
Total Funding:
10.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Global Site Tag Euro
Current Advisors List
Current Employees Featured
Founder
Investors List
Tau Ventures
Tau Ventures investment in Series A - Biotia
Phoenix Venture Partners
Phoenix Venture Partners investment in Series A - Biotia
SpringTide Ventures
SpringTide Ventures investment in Series A - Biotia
SeedToB Capital
SeedToB Capital investment in Series A - Biotia
SK Square Americas
SK Square Americas investment in Series A - Biotia
Mayo Clinic Platform
Mayo Clinic Platform investment in Series A - Biotia
OCA Ventures
OCA Ventures investment in Series A - Biotia
Continuum Health Ventures
Continuum Health Ventures investment in Series A - Biotia
DigitalDx Ventures
DigitalDx Ventures investment in Series A - Biotia
Leawood Venture Capital
Leawood Venture Capital investment in Series A - Biotia
Official Site Inspections
http://www.biotia.io Semrush global rank: 4.69 M Semrush visits lastest month: 2.06 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Biotia"
About | Advancing Infectious Disease Solutions with โฆ
As of 2020, Biotia was accredited as a fully operational CLEP and high complexity CLIA-certified laboratory by the NY State Department of Health. New York State has the most stringent regulatory compliance requirements of any state in the โฆSee details»
Biotia - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 888 685 2885 Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid and precise infectious disease discovery.See details»
Biotia - LinkedIn
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid precision infectious disease discovery.See details»
Biotia and Partners Develop Tracking Platform to Help Prevent โฆ
The partnership expands the collaboration with MetaSUB, a nonprofit organization launched by Dr. Chris Mason, cofounder and global director of Biotia, that conducts microbial tracking and โฆSee details»
Biotia Company Profile - Office Locations, Competitors, Revenue
Biotia is a health tech company using sequencing and proprietary bioinformatics technology to reduce hospital-acquired infections. It develops and implements its diagnostic testing methods, โฆSee details»
Biotia | VentureRadar
Biotia is a health tech company launched from Jacobs Technion-Cornell Institute at Cornell Tech in association with Weill Cornell Medicine, located in New York, NY, that leverages DNA โฆSee details»
Biotia - Overview, News & Similar companies | ZoomInfo.com
Feb 5, 2023 Biotia contact info: Phone number: (888) 685-2885 Website: www.biotia.io What does Biotia do? Biotia is a health tech company located in New York, NY that leverages โฆSee details»
The Fund Founder Spotlight Interview: Niamh O'Hara of Biotia
Jan 11, 2023 What is Biotiaโs Northstar? Science. We're mostly a bunch of scientists, the majority coming out of Cornell, Cornell Tech, Weill Cornell, and Columbia University. We use a โฆSee details»
Biotia Company Profile 2024: Valuation, Funding & Investors
Biotia General Information Description. Developer of a laboratory technology designed to provide tailored sequencing to reduce hospital-acquired infections. The company provides microbial โฆSee details»
Biotia
Biotia is working with clinicians and researchers to leverage high-complexity tests and AI for rapid precision infectious disease discovery to guide patient treatment and improve health โฆSee details»
Pasteur Network and GeoSeeq Foundation Partner to Tackle
Oct 31, 2023 Complex global challenges are best addressed by unlocking the power of existing networks and empowering institutes anchored in local communities. This new partnership โฆSee details»
Biotia Company Profile: Overview and Full News Analysis
Biotia has collaborated with various organizations such as The Rockefeller Foundation, Cornell Tech, Mayo Clinic, and others to develop innovative solutions for infectious disease โฆSee details»
Biotia - Company Profile - Tracxn
5 days ago Biotia - Provider of sequencing-based solutions for hospitals. Raised a total funding of $10.4M over 2 rounds from 18 investors. Founded by Niamh O'Hara, Christopher Mason โฆSee details»
Biotia, Pioneering Pathogen Detection Company, Raises An โฆ
New York, NY -- August 23, 2022 -- Biotia, a company fighting infectious diseases powered by genomics and artificial intelligence (AI), has raised an oversubscribed $8 million Series A โฆSee details»
Biotia - Products, Competitors, Financials, Employees, โฆ
Nov 4, 2024 Biotia is actively working with leading medical institutions and laboratories to integrate its product into clinical workflows, and insurance providers to ensure that BIOTIA-ID โฆSee details»
Press Releases | Biotia
Discover Biotia's Impact - Read our latest press releases highlighting collaborations, breakthroughs, and contributions in genomics, AI, and infectious disease research. ... 685 โฆSee details»
News - Biotia
Biotia is a proud supporting partner of the XPRIZE Rapid Covid Testing Competition, which recently announced the 5 winning teams that created high-quality, affordable COVID-19 โฆSee details»